Comparison of two plasma-derived hepatitis B vaccines: Long-term report of a prospective, randomized trial
โ Scribed by J. Y. N. LAU; C. L. LAI; P. C. WU; H. J. LIN
- Book ID
- 118703861
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 456 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A total of 318 children were prospectively randomized in group 1 with two 5-g doses of recombinant vaccine given at 0 and 1 month; in group 2 with three 5-g doses of recombinant vaccine given at 0, 1, and 6 months; or in group 3 with three doses of plasma-derived vaccine given at 0, 1, and 6 months.
In a prospective randomized trial, 318 children aged between 3 mo and 11 yr who were negative for all hepatitis B markers were randomized to receive two 5-pg doses of hepatitis B recombinant DNA yeast vaccine at 0 and 1 m o (group 11, three 5 -~g doses of hepatitis B recombinant DNA yeast vaccine at